Ticker Details
Immunovant, Inc.
IPO Date:	June 7, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$8.44B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.59 | 2.96%
Avg Daily Range (30 D):	$0.86 | 2.47%
Avg Daily Range (90 D):	$0.78 | 2.67%

Institutional Daily Volume
Avg Daily Volume:	.84M
Avg Daily Volume (30 D):	1.25M
Avg Daily Volume (90 D):	1.42M

Trade Size
Avg Trade Size (Sh.):	75
Avg Trade Size (Sh.) (30 D):	57
Avg Trade Size (Sh.) (90 D):	66

Institutional Trades
Total Institutional Trades:	3,382
Avg Institutional Trade:	$2.41M
Avg Institutional Trade (30 D):	$5.34M
Avg Institutional Trade (90 D):	$3.62M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.93M
Avg Closing Trade (30 D):	$10.84M
Avg Closing Trade (90 D):	$7.21M
Avg Closing Volume:	169.19K

News

Jun 22, 2026 @ 5:00 PM Cutaneous Lupus Erythematosus Market to Expand at ... Source: Delveinsight

Jun 2, 2026 @ 5:00 PM Myasthenia Gravis Clinical Trial Pipeline Expands ... Source: Delveinsight

Apr 15, 2026 @ 5:00 PM Generalized Myasthenia Gravis Market on the Brink ... Source: Delveinsight

Apr 2, 2026 @ 9:00 AM Immunovant Announces Phase 3 Study Results for Bat... Source: Na

Feb 6, 2026 @ 12:00 PM Immunovant Provides Corporate Updates and Reports ... Source: Immunovant, Inc.

Financials
	TTM	Q4 2026	FY 2026
Basic EPS	$-2.77	$-.73	$-2.77
Diluted EPS	$-2.77	$-.73	$-2.77
Revenue
Gross Profit
Net Income / Loss	$-505.61M	$-147.86M	$-505.61M
Operating Income / Loss
Cost of Revenue
Net Cash Flow	$188.14M	$188.83M	$188.14M
PE Ratio